Delivery of chemotherapy and antibodies across the blood-brain barrier and the role of chemoprotection, in primary and metastatic brain tumors: Report of the eleventh annual blood-brain barrier consortium meeting

Nancy D. Doolittle, David M. Peereboom, Gregory A. Christoforidis, Walter A. Hall, Diane Palmieri, Penelope R. Brock, Kathleen C M Campbell, D. Thomas Dickey, Leslie L. Muldoon, Brian Patrick O'Neill, Darryl R. Peterson, Bradley H Pollock, Carole Soussain, Quentin Smith, Rose Marie Tyson, Edward A. Neuwelt

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Although knowledge of molecular biology and cellular physiology has advanced at a rapid pace, much remains to be learned about delivering chemotherapy and antibodies across the blood-brain barrier (BBB) for the diagnosis and treatment of central nervous system (CNS) disease. A meeting, partially funded by an NIH R13 grant, was convened to discuss the state of the science, current knowledge gaps, and future directions in the delivery of drugs and proteins to the CNS, for the treatment of primary and metastatic brain tumors. Meeting topics included CNS metastases and the BBB, and chemoprotection and chemoenhancement in CNS disorders. The discussions regarding CNS metastases generated possibilities of chemoprotection as a means not only to decrease treatment-related toxicity but also to increase chemotherapy dose intensity. The increasing incidence of sanctuary brain metastasis from breast cancer, in part due to the difficulty of monoclonal antibodies (mAbs) such as herceptin to cross the BBB, was one of the most salient "take home" messages of the meeting.

Original languageEnglish (US)
Pages (from-to)81-91
Number of pages11
JournalJournal of Neuro-Oncology
Volume81
Issue number1
DOIs
StatePublished - Jan 2007
Externally publishedYes

Fingerprint

Annual Reports
Blood-Brain Barrier
Brain Neoplasms
Central Nervous System
Central Nervous System Diseases
Neoplasm Metastasis
Drug Therapy
Antibodies
Organized Financing
Molecular Biology
Therapeutics
Monoclonal Antibodies
Breast Neoplasms
Incidence
Brain
Pharmaceutical Preparations
Proteins

Keywords

  • Blood-brain barrier
  • Brain delivery
  • Brain metastases
  • Brain tumors
  • Chemoprotection

ASJC Scopus subject areas

  • Clinical Neurology
  • Cancer Research
  • Oncology
  • Neuroscience(all)

Cite this

Delivery of chemotherapy and antibodies across the blood-brain barrier and the role of chemoprotection, in primary and metastatic brain tumors : Report of the eleventh annual blood-brain barrier consortium meeting. / Doolittle, Nancy D.; Peereboom, David M.; Christoforidis, Gregory A.; Hall, Walter A.; Palmieri, Diane; Brock, Penelope R.; Campbell, Kathleen C M; Dickey, D. Thomas; Muldoon, Leslie L.; O'Neill, Brian Patrick; Peterson, Darryl R.; Pollock, Bradley H; Soussain, Carole; Smith, Quentin; Tyson, Rose Marie; Neuwelt, Edward A.

In: Journal of Neuro-Oncology, Vol. 81, No. 1, 01.2007, p. 81-91.

Research output: Contribution to journalArticle

Doolittle, ND, Peereboom, DM, Christoforidis, GA, Hall, WA, Palmieri, D, Brock, PR, Campbell, KCM, Dickey, DT, Muldoon, LL, O'Neill, BP, Peterson, DR, Pollock, BH, Soussain, C, Smith, Q, Tyson, RM & Neuwelt, EA 2007, 'Delivery of chemotherapy and antibodies across the blood-brain barrier and the role of chemoprotection, in primary and metastatic brain tumors: Report of the eleventh annual blood-brain barrier consortium meeting', Journal of Neuro-Oncology, vol. 81, no. 1, pp. 81-91. https://doi.org/10.1007/s11060-006-9209-y
Doolittle, Nancy D. ; Peereboom, David M. ; Christoforidis, Gregory A. ; Hall, Walter A. ; Palmieri, Diane ; Brock, Penelope R. ; Campbell, Kathleen C M ; Dickey, D. Thomas ; Muldoon, Leslie L. ; O'Neill, Brian Patrick ; Peterson, Darryl R. ; Pollock, Bradley H ; Soussain, Carole ; Smith, Quentin ; Tyson, Rose Marie ; Neuwelt, Edward A. / Delivery of chemotherapy and antibodies across the blood-brain barrier and the role of chemoprotection, in primary and metastatic brain tumors : Report of the eleventh annual blood-brain barrier consortium meeting. In: Journal of Neuro-Oncology. 2007 ; Vol. 81, No. 1. pp. 81-91.
@article{885d56a1ad36472f89f419032c909f69,
title = "Delivery of chemotherapy and antibodies across the blood-brain barrier and the role of chemoprotection, in primary and metastatic brain tumors: Report of the eleventh annual blood-brain barrier consortium meeting",
abstract = "Although knowledge of molecular biology and cellular physiology has advanced at a rapid pace, much remains to be learned about delivering chemotherapy and antibodies across the blood-brain barrier (BBB) for the diagnosis and treatment of central nervous system (CNS) disease. A meeting, partially funded by an NIH R13 grant, was convened to discuss the state of the science, current knowledge gaps, and future directions in the delivery of drugs and proteins to the CNS, for the treatment of primary and metastatic brain tumors. Meeting topics included CNS metastases and the BBB, and chemoprotection and chemoenhancement in CNS disorders. The discussions regarding CNS metastases generated possibilities of chemoprotection as a means not only to decrease treatment-related toxicity but also to increase chemotherapy dose intensity. The increasing incidence of sanctuary brain metastasis from breast cancer, in part due to the difficulty of monoclonal antibodies (mAbs) such as herceptin to cross the BBB, was one of the most salient {"}take home{"} messages of the meeting.",
keywords = "Blood-brain barrier, Brain delivery, Brain metastases, Brain tumors, Chemoprotection",
author = "Doolittle, {Nancy D.} and Peereboom, {David M.} and Christoforidis, {Gregory A.} and Hall, {Walter A.} and Diane Palmieri and Brock, {Penelope R.} and Campbell, {Kathleen C M} and Dickey, {D. Thomas} and Muldoon, {Leslie L.} and O'Neill, {Brian Patrick} and Peterson, {Darryl R.} and Pollock, {Bradley H} and Carole Soussain and Quentin Smith and Tyson, {Rose Marie} and Neuwelt, {Edward A.}",
year = "2007",
month = "1",
doi = "10.1007/s11060-006-9209-y",
language = "English (US)",
volume = "81",
pages = "81--91",
journal = "Journal of Neuro-Oncology",
issn = "0167-594X",
publisher = "Kluwer Academic Publishers",
number = "1",

}

TY - JOUR

T1 - Delivery of chemotherapy and antibodies across the blood-brain barrier and the role of chemoprotection, in primary and metastatic brain tumors

T2 - Report of the eleventh annual blood-brain barrier consortium meeting

AU - Doolittle, Nancy D.

AU - Peereboom, David M.

AU - Christoforidis, Gregory A.

AU - Hall, Walter A.

AU - Palmieri, Diane

AU - Brock, Penelope R.

AU - Campbell, Kathleen C M

AU - Dickey, D. Thomas

AU - Muldoon, Leslie L.

AU - O'Neill, Brian Patrick

AU - Peterson, Darryl R.

AU - Pollock, Bradley H

AU - Soussain, Carole

AU - Smith, Quentin

AU - Tyson, Rose Marie

AU - Neuwelt, Edward A.

PY - 2007/1

Y1 - 2007/1

N2 - Although knowledge of molecular biology and cellular physiology has advanced at a rapid pace, much remains to be learned about delivering chemotherapy and antibodies across the blood-brain barrier (BBB) for the diagnosis and treatment of central nervous system (CNS) disease. A meeting, partially funded by an NIH R13 grant, was convened to discuss the state of the science, current knowledge gaps, and future directions in the delivery of drugs and proteins to the CNS, for the treatment of primary and metastatic brain tumors. Meeting topics included CNS metastases and the BBB, and chemoprotection and chemoenhancement in CNS disorders. The discussions regarding CNS metastases generated possibilities of chemoprotection as a means not only to decrease treatment-related toxicity but also to increase chemotherapy dose intensity. The increasing incidence of sanctuary brain metastasis from breast cancer, in part due to the difficulty of monoclonal antibodies (mAbs) such as herceptin to cross the BBB, was one of the most salient "take home" messages of the meeting.

AB - Although knowledge of molecular biology and cellular physiology has advanced at a rapid pace, much remains to be learned about delivering chemotherapy and antibodies across the blood-brain barrier (BBB) for the diagnosis and treatment of central nervous system (CNS) disease. A meeting, partially funded by an NIH R13 grant, was convened to discuss the state of the science, current knowledge gaps, and future directions in the delivery of drugs and proteins to the CNS, for the treatment of primary and metastatic brain tumors. Meeting topics included CNS metastases and the BBB, and chemoprotection and chemoenhancement in CNS disorders. The discussions regarding CNS metastases generated possibilities of chemoprotection as a means not only to decrease treatment-related toxicity but also to increase chemotherapy dose intensity. The increasing incidence of sanctuary brain metastasis from breast cancer, in part due to the difficulty of monoclonal antibodies (mAbs) such as herceptin to cross the BBB, was one of the most salient "take home" messages of the meeting.

KW - Blood-brain barrier

KW - Brain delivery

KW - Brain metastases

KW - Brain tumors

KW - Chemoprotection

UR - http://www.scopus.com/inward/record.url?scp=33845694512&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845694512&partnerID=8YFLogxK

U2 - 10.1007/s11060-006-9209-y

DO - 10.1007/s11060-006-9209-y

M3 - Article

C2 - 16858513

AN - SCOPUS:33845694512

VL - 81

SP - 81

EP - 91

JO - Journal of Neuro-Oncology

JF - Journal of Neuro-Oncology

SN - 0167-594X

IS - 1

ER -